查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1671178

皮肤科治疗药的全球市场:市场规模·占有率·趋势，产业分析 (不同治疗·各类型·各给药途径·各流通管道·各类药物·各地区)，未来预测 (2025年～2034年)

Dermatology Drugs Market Size, Share, Trends, Industry Analysis Report: By Therapy, Type, Route of Administration, Distribution Channel, Drug Class, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，皮肤病药物市场预计到 2034 年将达到 661.5 亿美元。该报告提供了有关当前市场动态的详细见解，并对未来市场的成长进行了分析。

皮肤病药物市场的成长主要得益于痤疮、牛皮癣、湿疹和皮肤癌等皮肤病的发病率不断上升以及治疗方案的进步。主要驱动因素包括对生物製剂和标靶治疗的需求不断增长，特别是针对慢性和严重皮肤病，以及人们对皮肤健康的认识不断提高。由于非处方药（OTC）的扩张和使用基因检测进行个人化皮肤病治疗的日益增加，皮肤病药物的市场机会存在。

美容皮肤病治疗的兴起、外用药物配方的创新以及为提高患者参与度而整合的数位健康解决方案等趋势正在塑造市场。随着此类先进治疗方法的不断普及以及新兴市场医疗保健管道的不断拓宽，皮肤病药物市场预计将继续成长。

皮肤病治疗市场：分析概述

根据治疗，痤疮治疗部分占皮肤病药物市场收入的最大份额。这是因为痤疮发病率很高，尤其是在青少年和年轻人中，并且外用和口服治疗的广泛使用。牛皮癣也是一个重要的细分领域，生物製剂和标靶疗法的采用推动了强劲成长。

处方药在皮肤科药物市场中占据主导地位，因为牛皮癣和湿疹等慢性皮肤病需要专门治疗。随着越来越多的消费者青睐便利且经济高效的自我保健选择，非处方（OTC）药品产业正在迅速成长。

依给药途径划分，外用药物占比最大，是多种皮肤病的第一线治疗方法。口服药物领域成长最快，尤其是由于推出了新的口服生物製剂和针对痤疮和牛皮癣等疾病的系统治疗方法。

根据分销管道，医院药房部分占据最大的市场份额，主要是由于对严重皮肤病的专门治疗的需求。由于非处方皮肤病产品的需求不断增加以及消费者获得这些治疗的机会不断扩大，零售药局领域是成长最快的领域。

北美凭藉其先进的医疗保健体系、较高的皮肤病学认知度以及製药公司的强大市场影响力，占据了全球皮肤病药物市场的主导地位。亚太地区是成长最快的地区，其推动力是医疗保健机会的增加、认识的提高以及对皮肤病治疗的需求不断增长。

皮肤病治疗市场的主要参与者包括艾伯维、Elilily·与·公司，强生，诺华，GlaxoSmithKline Plc，amujen，辉瑞，Sanofi，拜耳，默克·与·公司，UCB，布里斯托尔·maiyazusukuibu，欧莱雅，garuderuma，meda·famashutikaruzu等。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球皮肤科治疗药市场洞察

  • 市场概述
  • 皮肤科治疗药的市场动态
    • 促进因素和机会
      • 皮肤病学对生物製品的需求不断增加
      • 外用药物和非处方 (OTC) 药物的转变
    • 阻碍因素和挑战
      • 护肤药物成本高
  • 大环境分析
  • 皮肤科治疗药市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球皮肤科治疗药市场:不同治疗

  • 主要的分析结果
  • 简介
  • 痤疮
  • 干癣
  • 酒糟先生皮肤炎
  • 脱髮症
  • 其他

第6章 全球皮肤科治疗药市场:各类型

  • 主要的分析结果
  • 处方笺
  • 店面销售(OTC)

第7章 全球皮肤科治疗药市场:各给药途径

  • 主要的分析结果
  • 简介
  • 局部
  • 口服
  • 非口服

第8章 全球皮肤科治疗药市场:各流通管道

  • 主要的分析结果
  • 简介
  • 医院药局
  • 零售药局
  • 其他

第9章 全球皮肤科治疗药市场:各类药物

  • 主要的分析结果
  • 简介
  • 抗感染药物
  • 皮质类固醇
  • 预防痤疮
  • 钙调磷酸酶抑制剂
  • 类视黄酸
  • 其他

第10章 全球皮肤科治疗药市场:各地区

  • 主要的分析结果
  • 简介
    • 皮肤科治疗药市场评估:各地区 (2020～2034年)
  • 北美
    • 北美:不同治疗 (2020～2034年)
    • 北美:各类型 (2020～2034年)
    • 北美:各给药途径 (2020～2034年)
    • 北美:各流通管道 (2020～2034年)
    • 北美:各类药物 (2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:不同治疗 (2020～2034年)
    • 欧洲:各类型 (2020～2034年)
    • 欧洲:各给药途径 (2020～2034年)
    • 欧洲:各流通管道 (2020～2034年)
    • 欧洲:各类药物 (2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:不同治疗 (2020～2034年)
    • 亚太地区:各类型 (2020～2034年)
    • 亚太地区:各给药途径 (2020～2034年)
    • 亚太地区:各流通管道 (2020～2034年)
    • 亚太地区:各类药物 (2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:不同治疗 (2020～2034年)
    • 中东·非洲:各类型 (2020～2034年)
    • 中东·非洲:各给药途径 (2020～2034年)
    • 中东·非洲:各流通管道 (2020～2034年)
    • 中东·非洲:各类药物 (2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:不同治疗 (2020～2034年)
    • 南美:各类型 (2020～2034年)
    • 南美:各给药途径 (2020～2034年)
    • 南美:各流通管道 (2020～2034年)
    • 南美:各类药物 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • AbbVie
  • Amgen
  • Bayer
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Galderma
  • GlaxoSmithKline
  • Johnson & Johnson
  • L'Oreal
  • Meda Pharmaceuticals
Product Code: PM1106

The dermatology drugs market size is expected to reach USD 66.15 billion by 2034, according to a new study by Polaris Market Research. The report "Dermatology Drugs Market Size, Share, Trends, Industry Analysis Report: By Therapy (Acne, Psoriasis, Rosacea, Alopecia, and Others), Type, Route of Administration, Distribution Channel, Drug Class, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The dermatology drugs market growth is significantly driven by an increasing prevalence of skin conditions, such as acne, psoriasis, eczema, and skin cancer, coupled with advancements in treatment options. Key drivers include the rising demand for biologics and targeted therapies, particularly for chronic and severe skin diseases, as well as the growing awareness about skin health. Dermatology drugs market opportunities exist in the expansion of over-the-counter (OTC) products and the increasing shift toward personalized dermatology treatments, leveraging genetic testing for more tailored care.

Trends such as the rise in aesthetic dermatology treatments, innovations in topical drug formulations, and the integration of digital health solutions for improved patient engagement are shaping the market. With the growing adoption of these advanced treatments and increasing healthcare access in emerging markets, the dermatology drugs market is poised for continued growth.

Dermatology Drugs Market Report Highlights:

Based on therapy, the acne therapy segment holds the largest share of the dermatology drugs market revenue due to the high prevalence of acne, especially among teens and young adults, and the widespread use of topical and oral treatments. Psoriasis is also a significant segment, with strong growth driven by the adoption of biologics and targeted therapies.

The prescription drugs segment, by type, dominates the dermatology drugs market share due to the need for specialized treatments for chronic skin conditions, such as psoriasis and eczema. The over-the-counter (OTC) segment is growing rapidly, driven by increasing consumer preference for accessible, cost-effective self-care solutions.

In terms of route of administration, the topical segment holds the largest share, as it is the first-line treatment for many skin conditions. The oral segment is registering the highest growth, especially with the introduction of new oral biologics and systemic treatments for conditions such as acne and psoriasis.

The hospital pharmacies segment, by distribution channel, holds the largest market share, primarily due to the demand for specialized treatments for severe dermatological conditions. The retail pharmacies segment is the fastest-growing segment, driven by the increasing demand for OTC dermatology products and greater consumer access to these treatments.

North America dominates the global dermatology drugs market share due to advanced healthcare systems, high dermatology awareness, and strong market presence of pharmaceutical companies. Asia Pacific is the fastest-growing region, driven by increasing healthcare access, rising awareness, and growing demand for dermatology treatments.

A few key players in the dermatology drugs market are AbbVie, Eli Lilly and Company, Johnson & Johnson, Novartis, GlaxoSmithKline, Amgen, Pfizer, Sanofi, Bayer, Merck & Co., UCB, Bristol-Myers Squibb, L'Oreal, Galderma, and Meda Pharmaceuticals.

Polaris Market Research has segmented the dermatology drugs market report on the basis of therapy, type, route of administration, distribution channel, drug class, and region:

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

  • Acne
  • Psoriasis
  • Rosacea
  • Alopecia
  • Others

By Type Outlook (Revenue - USD Billion, 2020-2034)

  • Prescription
  • Over-the-Counter (OTC)

By Route of Administration Outlook (Revenue - USD Billion, 2020-2034)

  • Topical
  • Oral
  • Parenteral

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Drug Class Outlook (Revenue - USD Billion, 2020-2034)

  • Anti-Infectives
  • Corticosteroids
  • Anti-Acne
  • Calcineurin Inhibitors
  • Retinoids
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dermatology Drugs Market Insights

  • 4.1. Dermatology Drugs Market - Frequency Snapshot
  • 4.2. Dermatology Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Demand for Biologics in Dermatology
      • 4.2.1.2. Shift Toward Topical Treatments and Over-the-Counter (OTC) Products
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Dermatology Drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dermatology Drugs Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dermatology Drugs Market, by Therapy

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • 5.3. Acne
    • 5.3.1. Global Dermatology Drugs Market, Acne, by Region, 2020-2034 (USD Billion)
  • 5.4. Psoriasis
    • 5.4.1. Global Dermatology Drugs Market, by Psoriasis, by Region, 2020-2034 (USD Billion)
  • 5.5. Rosacea
    • 5.5.1. Global Dermatology Drugs Market, by Rosacea, by Region, 2020-2034 (USD Billion)
  • 5.6. Alopecia
    • 5.6.1. Global Dermatology Drugs Market, by Alopecia, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Dermatology Drugs Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • 6.3. Prescription
    • 6.3.1. Global Dermatology Drugs Market, by Prescription, by Region, 2020-2034 (USD Billion)
  • 6.4. Over-the-Counter (OTC)
    • 6.4.1. Global Dermatology Drugs Market, by Over-the-Counter (OTC), by Region, 2020-2034 (USD Billion)

7. Global Dermatology Drugs Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Topical
    • 7.3.1. Global Dermatology Drugs Market, by Topical, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral
    • 7.4.1. Global Dermatology Drugs Market, Oral, by Region, 2020-2034 (USD Billion)
  • 7.5. Parenteral
    • 7.5.1. Global Dermatology Drugs Market, Parenteral, by Region, 2020-2034 (USD Billion)

8. Global Dermatology Drugs Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global Dermatology Drugs Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.4. Retail Pharmacies
    • 8.4.1. Global Dermatology Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Dermatology Drugs Market, by Drug Class

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 9.3. Anti-Infectives
    • 9.3.1. Global Dermatology Drugs Market, by Anti-Infectives, by Region, 2020-2034 (USD Billion)
  • 9.4. Corticosteroids
    • 9.4.1. Global Dermatology Drugs Market, by Corticosteroids, by Region, 2020-2034 (USD Billion)
  • 9.5. Anti-Acne
    • 9.5.1. Global Dermatology Drugs Market, by Anti-Acne, by Region, 2020-2034 (USD Billion)
  • 9.6. Calcineurin Inhibitors
    • 9.6.1. Global Dermatology Drugs Market, by Calcineurin Inhibitors, by Region, 2020-2034 (USD Billion)
  • 9.7. Retinoids
    • 9.7.1. Global Dermatology Drugs Market, by Retinoids, by Region, 2020-2034 (USD Billion)
  • 9.8. Others
    • 9.8.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Dermatology Drugs Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Dermatology Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Dermatology Drugs Market - North America
    • 10.3.1. North America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.3.2. North America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.3.3. North America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.3.4. North America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.3.5. North America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.3.7. Dermatology Drugs Market - U.S.
      • 10.3.7.1. U.S.: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.3.7.2. U.S.: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.3. U.S.: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.7.4. U.S.: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.3.7.5. U.S.: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.3.8. Dermatology Drugs Market - Canada
      • 10.3.8.1. Canada: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.4. Dermatology Drugs Market - Europe
    • 10.4.1. Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.6. Dermatology Drugs Market - UK
      • 10.4.6.1. UK: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.7. Dermatology Drugs Market - France
      • 10.4.7.1. France: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.8. Dermatology Drugs Market - Germany
      • 10.4.8.1. Germany: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.9. Dermatology Drugs Market - Italy
      • 10.4.9.1. Italy: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.10. Dermatology Drugs Market - Spain
      • 10.4.10.1. Spain: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.11. Dermatology Drugs Market - Netherlands
      • 10.4.11.1. Netherlands: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.12. Dermatology Drugs Market - Russia
      • 10.4.12.1. Russia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.13. Dermatology Drugs Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.5. Dermatology Drugs Market - Asia Pacific
    • 10.5.1. Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.6. Dermatology Drugs Market - China
      • 10.5.6.1. China: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.7. Dermatology Drugs Market - India
      • 10.5.7.1. India: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.8. Dermatology Drugs Market - Malaysia
      • 10.5.8.1. Malaysia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.9. Dermatology Drugs Market - Japan
      • 10.5.9.1. Japan: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.10. Dermatology Drugs Market - Indonesia
      • 10.5.10.1. Indonesia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.11. Dermatology Drugs Market - South Korea
      • 10.5.11.1. South Korea: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.12. Dermatology Drugs Market - Australia
      • 10.5.12.1. Australia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.13. Dermatology Drugs Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.6. Dermatology Drugs Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.6. Dermatology Drugs Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.7. Dermatology Drugs Market - UAE
      • 10.6.7.1. UAE: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.8. Dermatology Drugs Market - Israel
      • 10.6.8.1. Israel: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.9. Dermatology Drugs Market - South Africa
      • 10.6.9.1. South Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.10. Dermatology Drugs Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.7. Dermatology Drugs Market - Latin America
    • 10.7.1. Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.6. Dermatology Drugs Market - Mexico
      • 10.7.6.1. Mexico: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.7. Dermatology Drugs Market - Brazil
      • 10.7.7.1. Brazil: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.8. Dermatology Drugs Market - Argentina
      • 10.7.8.1. Argentina: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.9. Dermatology Drugs Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AbbVie
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Amgen
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Bayer
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Bristol-Myers Squibb
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Eli Lilly and Company
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Galderma
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. GlaxoSmithKline
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Johnson & Johnson
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. L'Oreal
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Meda Pharmaceuticals
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development

List of Tables:

  • Table 1 Global Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 2 Global Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 3 Global Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 4 Global Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 5 Global Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 6 North America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 7 North America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 8 North America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 9 North America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 North America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 11 U.S.: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 12 U.S.: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 13 U.S.: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 14 U.S.: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 15 U.S.: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 16 Canada: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 17 Canada: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Canada: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 19 Canada: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 20 Canada: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 21 Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 22 Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 24 Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 26 UK: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 27 UK: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 28 UK: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 29 UK: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 30 UK: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 31 France: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 32 France: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 33 France: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 34 France: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 35 France: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 36 Germany: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 37 Germany: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Germany: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 39 Germany: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Germany: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 41 Italy: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 42 Italy: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 43 Italy: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 44 Italy: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 Italy: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 46 Spain: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 47 Spain: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Spain: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 49 Spain: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 50 Spain: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 56 Russia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 57 Russia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 58 Russia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 59 Russia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 60 Russia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 71 China: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 72 China: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 73 China: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 74 China: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 75 China: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 76 India: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 77 India: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 78 India: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 79 India: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 80 India: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 86 Japan: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 87 Japan: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 88 Japan: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 89 Japan: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 90 Japan: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 96 South Korea: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 97 South Korea: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 98 South Korea: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 99 South Korea: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 100 South Korea: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 101 Australia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 102 Australia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 103 Australia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 104 Australia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 105 Australia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 121 UAE: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 122 UAE: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 123 UAE: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 124 UAE: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 125 UAE: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 126 Israel: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 127 Israel: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 128 Israel: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 129 Israel: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 130 Israel: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 131 South Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 132 South Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 133 South Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 134 South Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 135 South Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 141 Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 142 Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 143 Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 144 Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 145 Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 146 Mexico: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 147 Mexico: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 148 Mexico: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 149 Mexico: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 150 Mexico: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 151 Brazil: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 152 Brazil: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 153 Brazil: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 154 Brazil: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 155 Brazil: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 156 Argentina: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 157 Argentina: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 158 Argentina: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 159 Argentina: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 160 Argentina: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Dermatology Drugs Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapy
  • Figure 7. Global Dermatology Drugs Market, by Therapy, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Dermatology Drugs Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Dermatology Drugs Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Dermatology Drugs Market, by Distribution Channel, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Drug Class
  • Figure 15. Global Dermatology Drugs Market, by Drug Class, 2024 & 2034 (USD Billion)